Related Experiment Videos
MyD genes in negative growth control
1Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.
Abstract:
Two interrelated cellular processes are invoked simultaneously upon induction of differentiation, the regulated progression of cells through successive stages of cell differentiation and growth inhibition which ultimately leads to growth arrest. In tissues with rapid cell turnover terminally differentiated cells undergo programmed cell death. Terminal differentiation, thus, represents one form of negative growth control. It was surmised that the molecular engine which drives the differentiation process forward requires induction of positive regulators of terminal cell differentiation, to be found among differentiation primary response genes, as well as suppression of negative regulators, which correspond to genes which control cellular growth. This line of thought has prompted the isolation of myeloid differentiation primary response (MyD) genes activated in the absence of de novo protein synthesis, upon IL-6 induced terminal differentiation of murine M1 myeloblastic leukemia cells, where the cells growth arrest and ultimately undergo programmed cell death. As delineated in this review many of the genes identified as MyD genes, including both known genes [IRF-1, (AP-1)Fos/Jun.EGR-1] and novel ones (MyD88, MyD116, MyD118), turned out to play a role in negative growth control, including growth suppression and apoptosis, in many cell types, of both hematopoietic and non hematopoietic origins.
Insights
Cell differentiation involves growth arrest and programmed cell death, regulated by specific genes. Myeloid differentiation primary response (MyD) genes identified in leukemia cells control cell growth and apoptosis.
Area of Science:
- Cellular Biology
- Molecular Biology
- Cancer Research
Background:
- Cell differentiation is a complex process involving growth inhibition and eventual growth arrest.
- Terminal differentiation, particularly in rapidly dividing tissues, culminates in programmed cell death, acting as a negative growth control mechanism.
- The molecular mechanisms driving differentiation involve both positive regulators (differentiation primary response genes) and suppression of negative regulators (growth control genes).
Purpose of the Study:
- To identify and characterize myeloid differentiation primary response (MyD) genes involved in IL-6 induced differentiation of M1 myeloblastic leukemia cells.
- To investigate the role of these MyD genes in regulating cell growth and inducing apoptosis.
- To understand the broader implications of MyD genes in negative growth control across various cell types.
Main Methods:
- Induction of terminal differentiation in murine M1 myeloblastic leukemia cells using Interleukin-6 (IL-6).
- Isolation of Myeloid differentiation primary response (MyD) genes activated in the absence of de novo protein synthesis.
- Analysis of known genes (e.g., IRF-1, AP-1, EGR-1) and novel genes (MyD88, MyD116, MyD118) identified as MyD genes.
Main Results:
- Identification of several MyD genes, including known regulators and novel candidates, activated during IL-6 induced differentiation.
- Demonstration that many identified MyD genes play a crucial role in negative growth control.
- Evidence that these genes contribute to growth suppression and apoptosis in both hematopoietic and non-hematopoietic cells.
Conclusions:
- Myeloid differentiation primary response (MyD) genes are critical molecular players in the process of terminal cell differentiation.
- These genes significantly contribute to negative growth control, mediating growth suppression and apoptosis.
- The findings highlight the conserved role of MyD genes in regulating cell fate and growth across diverse cell lineages.